Table of Contents Author Guidelines Submit a Manuscript
Advances in Urology
Volume 2017 (2017), Article ID 8541697, 7 pages
https://doi.org/10.1155/2017/8541697
Research Article

Distribution of Neuroendocrine Cells in the Transition Zone of the Prostate

Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan

Correspondence should be addressed to Naoya Masumori; pj.ca.dempas@iromusam

Received 11 November 2016; Revised 10 February 2017; Accepted 14 February 2017; Published 1 March 2017

Academic Editor: James A. Brown

Copyright © 2017 Yuki Kyoda et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Masumori, T. Tsukamoto, Y. Kumamoto et al., “Japanese men have smaller prostate volumes but comparable urinary flow rates relative to American men: results of community based studies in 2 countries,” Journal of Urology, vol. 155, no. 4, pp. 1324–1327, 1996. View at Publisher · View at Google Scholar · View at Scopus
  2. F. Fukuta, N. Masumori, M. Mori, and T. Tsukamoto, “Internal prostatic architecture on transrectal ultrasonography predicts future prostatic growth: natural history of prostatic hyperplasia in a 15-year longitudinal community-based study,” Prostate, vol. 71, no. 6, pp. 597–603, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Loeb, A. Kettermann, H. B. Carter, L. Ferrucci, E. J. Metter, and P. C. Walsh, “Prostate volume changes over time: results from the baltimore longitudinal study of aging,” Journal of Urology, vol. 182, no. 4, pp. 1458–1462, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. V. C. Mishra, D. J. Allen, C. Nicolaou et al., “Does intraprostatic inflammation have a role in the pathogenesis and progression of benign prostatic hyperplasia?” BJU International, vol. 100, no. 2, pp. 327–331, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. R. O. Roberts, D. J. Jacobson, T. Rhodes, G. G. Klee, M. M. Leiber, and S. J. Jacobsen, “Serum sex hormones and measures of benign prostatic hyperplasia,” Prostate, vol. 61, no. 2, pp. 124–131, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Bonkhoff, “Neuroendocrine cells in benign and malignant prostate tissue: morphogenesis, proliferation, and androgen receptor status,” The Prostate. Supplement, vol. 8, pp. 18–22, 1998. View at Google Scholar · View at Scopus
  7. Y. Xue, F. Smedts, A. Verhofstad, F. Debruyne, J. de la Rosette, and J. Schalken, “Cell kinetics of prostate exocrine and neuroendocrine epithelium and their differential interrelationship: new perspectives,” The Prostate Supplement, vol. 8, pp. 62–73, 1998. View at Google Scholar · View at Scopus
  8. A. T. K. Cockett, P. A. di Sant'Agnese, P. Gopinath, S. R. Schoen, and P.-A. Abrahamsson, “Relationship of neuroendocrine cells of prostate and serotonin to benign prostatic hyperplasia,” Urology, vol. 42, no. 5, pp. 512–519, 1993. View at Publisher · View at Google Scholar · View at Scopus
  9. A. H. M. Manjurul Islam, H. Kato, M. Hayama et al., “Are neuroendocrine cells responsible for the development of benign prostatic hyperplasia?” European Urology, vol. 42, no. 2, pp. 79–83, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. J. E. McNeal, “Origin and evolution of benign prostatic enlargement,” Investigative Urology, vol. 15, no. 4, pp. 340–345, 1978. View at Google Scholar · View at Scopus
  11. D. R. Greene, S. Egawa, D. K. Hellerstein, and P. T. Scardino, “Sonographic measurements of transition zone of prostate in men with and without benign prostatc hyperplasia,” Urology, vol. 36, no. 4, pp. 293–299, 1990. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Xue, J. Van Der Laak, F. Smedts et al., “Neuroendocrine cells during human prostate development: does neuroendocrine cell density remain constant during fetal as well as postnatal life?” Prostate, vol. 42, no. 2, pp. 116–123, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. C.-Y. Cheng, Z. Zhou, and A. Y. Nikitin, “Detection and organ-specific ablation of neuroendocrine cells by synaptophysin locus-based BAC cassette in transgenic mice,” PLOS ONE, vol. 8, no. 4, Article ID e60905, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. M. E. Harper, E. Glynne-Jones, L. Goddard, V. J. Thurston, and K. Griffiths, “Vascular endothelial growth factor (VEGF) expression in prostatic tumours and its relationship to neuroendocrine cells,” British Journal of Cancer, vol. 74, no. 6, pp. 910–916, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Heidenreich, J. Bellmunt, M. Bolla et al., “EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease,” European Urology, vol. 59, no. 1, pp. 61–71, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. J. E. Oesterling, “The origin and development of benign prostatic hyperplasia: an age-dependent process,” Journal of Andrology, vol. 12, no. 6, pp. 348–355, 1991. View at Google Scholar · View at Scopus
  17. L. I. Larsson, “On the possible existence of multiple endocrine, paracrine and neurocrine messengers in secretory cell systems,” Investigative and Cell Pathology, vol. 3, no. 1, pp. 73–85, 1980. View at Google Scholar · View at Scopus
  18. I. Ingelmo, V. Gómez, R. Martín et al., “Effect of prolactin and bromocriptine on the population of prostate neuroendocrine cells from intact and cyproterone acetate-treated rats: stereological and immunohistochemical study,” Anatomical Record, vol. 290, no. 7, pp. 855–861, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Rodríguez, J. M. Pozuelo, R. Martín et al., “Presence of neuroendocrine cells during postnatal development in rat prostate: immunohistochemical, molecular, and quantitative study,” Prostate, vol. 57, no. 2, pp. 176–185, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Robert, A. Descazeaud, N. Nicolaïew et al., “Inflammation in benign prostatic hyperplasia: a 282 patients' immunohistochemical analysis,” Prostate, vol. 69, no. 16, pp. 1774–1780, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Abrahamsson, “Neuroendocrine differentiation in prostatic carcinoma,” Prostate, vol. 39, no. 2, pp. 135–148, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Bonkhoff, U. Stein, and K. Remberger, “Androgen receptor status in endocrine-paracrine cell types of the normal, hyperplastic, and neoplastic human prostate,” Virchows Archiv A, vol. 423, no. 4, pp. 291–294, 1993. View at Publisher · View at Google Scholar · View at Scopus
  23. J. L. M. Krijnen, P. J. A. Janssen, J. A. Ruizeveld de Winter, H. van Krimpen, F. H. Schröder, and T. H. van der Kwast, “Do neuroendocrine cells in human prostate cancer express androgen receptor?” Histochemistry, vol. 100, no. 5, pp. 393–398, 1993. View at Publisher · View at Google Scholar · View at Scopus
  24. P. A. Abrahamsson, S. Falkmer, K. Falt, and L. Grimelius, “The course of neuroendocrine differentiation in prostatic carcinomas. An immunohistochemical study testing chromogranin A as an “endocrine marker”,” Pathology Research and Practice, vol. 185, no. 3, pp. 373–380, 1989. View at Publisher · View at Google Scholar · View at Scopus
  25. W. B. Huttner, H. H. Gerdes, and P. Rosa, “The granin-(chromogranin/secretogranin) family,” Trends in Biochemical Sciences, vol. 16, pp. 27–30, 1991. View at Publisher · View at Google Scholar · View at Scopus